Use of an angiotensin converting enzyme inhibitor in ocular hypertension and primary open-angle glaucoma.

Constad, W H; Fiore, P; Samson, C; Cinotti, A A

Constad, W H; Fiore, P; Samson, C; Cinotti, A A.

Affiliation

Constad WH; Department of Ophthalmology, University of Medicine and Dentistry of New Jersey, Newark.

Am J Ophthalmol ; 105(6): 674-7, 1988 Jun 15.

Article in En | MEDLINE | ID: mdl-3287943

Subject(s)

Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Glaucoma, Open-Angle/drug therapy; Ocular Hypertension/drug therapy; Phenylbutyrates/therapeutic use; Spiro Compounds/therapeutic use; Adult; Aged; Clinical Trials as Topic; Female; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension/physiopathology; Phenylbutyrates/adverse effects; Pulse/drug effects; Spiro Compounds/adverse effects; Time Factors; Timolol/therapeutic use

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Phenylbutyrates / Spiro Compounds / Angiotensin-Converting Enzyme Inhibitors / Glaucoma, Open-Angle / Ocular Hypertension Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Ophthalmol Year: 1988 Document type: Article

Search on Google

XML

PubMed Links